BSE Live
Feb 26, 13:15Prev. Close
5617.85
Open Price
5647.00
Bid Price (Qty.)
5686.50 (1)
Offer Price (Qty.)
5690.00 (11)
NSE Live
Feb 26, 13:15Prev. Close
5625.00
Open Price
5635.00
Bid Price (Qty.)
5689.00 (32)
Offer Price (Qty.)
5692.00 (17)
| Cash Flow of Alkem Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,338.08 | 943.96 | 934.29 | 894.43 | 838.85 | |
| Net CashFlow From Operating Activities | 681.78 | 745.09 | 318.26 | 499.06 | 629.82 | |
| Net Cash Used In Investing Activities | -995.17 | -313.06 | -273.11 | -361.90 | 310.81 | |
| Net Cash Used From Financing Activities | 172.64 | -275.75 | -59.98 | -124.64 | -958.16 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -140.75 | 156.28 | -14.83 | 12.52 | -17.48 | |
| Cash And Cash Equivalents Begin of Year | 161.44 | 5.16 | 19.99 | 7.47 | 24.95 | |
| Cash And Cash Equivalents End Of Year | 20.69 | 161.44 | 5.16 | 19.99 | 7.47 |
20.02.2026
20.02.2026
Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal
16.02.2026
13.01.2026
04.12.2025
Alkem Lab Consolidated September 2025 Net Sales at Rs 4,000.99 crore, up 17.17% Y-o-Y
24.11.2025
Alkem Lab Standalone September 2025 Net Sales at Rs 2,542.03 crore, down 11.49% Y-o-Y
10.09.2025
Alkem Lab Standalone June 2025 Net Sales at Rs 2,372.17 crore, down 5.12% Y-o-Y
12.08.2025
Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%
12.07.2023
Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang
17.10.2018
Alkem Labs Q2 PAT may dip 30.2% YoY to Rs. 220 cr: HDFC Securities
20.04.2018
Alkem Labs Q4 PAT may dip 1.5% YoY to Rs. 130 cr: HDFC Securities
12.04.2018
Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key